South Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency ...

HWASUN, July 7 (Yonhap) -- South Korea has developed the world's first recombinant protein-based anthrax vaccine, a major ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...

Biosafety level (BSL)-3 facilities exist in a diffuse regulatory environment, where requirements depend on factors such as the kinds of pathogens under study, the type of research being conducted, and ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...